| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/03/2013 | EP2610268A1 Modified antibodies with enhanced biological activities |
| 07/03/2013 | EP2609932A2 Variant target binding agents and uses thereof |
| 07/03/2013 | EP2608809A2 Antibodies to matrix metalloproteinase 9 |
| 07/03/2013 | CN1360678B Method for early detection of flaviviruses using NS1 glycoprotein and application thereof |
| 07/03/2013 | CN103189522A Novel artificial translation/synthesis system |
| 07/03/2013 | CN103189391A Novel antigen binding proteins |
| 07/03/2013 | CN103184262A Method for extracting and purifying pepsin-soluble collagens of black sea cucumber in East China Sea |
| 07/03/2013 | CN103184261A Co-production processing process of pharmaceutical gelatin and high-grade collagen |
| 07/03/2013 | CN103183739A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 07/03/2013 | CN103183729A Protein system associated with biosynthesis of gougerotin, and encoding gene cluster and application thereof |
| 07/03/2013 | CN102660521B Mutant of organic-solvent-resistant proteases |
| 07/03/2013 | CN102277402B Extraction method of nucleoprotein in animal cells |
| 07/03/2013 | CN101965403B Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 07/03/2013 | CN101935341B Polypeptide with activity of inhibiting beta-lactamase and preparation method and application thereof |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/02/2013 | US8476410 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 07/02/2013 | US8476052 Enzyme for the production of long chain peracid |
| 07/02/2013 | US8476051 Thermostable alcohol dehydrogenase derived from Thermococcus guaymasensis |
| 07/02/2013 | US8476042 Bacillus strain for increased protein production |
| 07/02/2013 | US8476041 Glucose transport mutants for production of biomaterial |
| 07/02/2013 | US8476040 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/02/2013 | US8476039 Hot spring bacterial strain BKH1 and protein isolated therefrom, concrete compositions, and uses thereof |
| 07/02/2013 | US8476027 Detection of cannabis use |
| 07/02/2013 | US8475806 High titer recombinant influenza viruses for vaccines and gene therapy |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
| 07/02/2013 | CA2649134C Synthesis of sialic acid in plants |
| 07/02/2013 | CA2438818C Rapid production of monoclonal antibodies |
| 07/02/2013 | CA2421151C Modified vaccinia ankara virus variant |
| 07/02/2013 | CA2408302C Long wavelength engineered fluorescent proteins |
| 07/02/2013 | CA2335376C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 06/27/2013 | WO2013096380A2 Anti-phf-tau antibodies and their uses |
| 06/27/2013 | WO2013096291A2 Modified polypeptides for bispecific antibody scaffolds |
| 06/27/2013 | WO2013094723A1 Novel anti-human ctgf antibody |
| 06/27/2013 | WO2013094080A1 Recombinant protein capable of specifically and rapidly binding to troponin-i originated from human cardiac muscles |
| 06/27/2013 | WO2013091924A1 Applications of an immune system-released activating agent (israa) |
| 06/27/2013 | WO2013091273A1 Method for producing wheat glutamine peptide |
| 06/27/2013 | WO2013044215A4 Vegf/dll4 binding agents and uses thereof |
| 06/27/2013 | WO2013040557A3 Rna engineered t cells for the treatment of cancer |
| 06/27/2013 | US20130165634 Expression and export of angiogenesis inhibitors as immunofusins |
| 06/27/2013 | US20130164823 Expression System |
| 06/27/2013 | US20130164787 Cell compositions derived from dedifferentiated reprogrammed cells |
| 06/27/2013 | US20130164786 Fucosylation-deficient cells |
| 06/27/2013 | US20130164784 Compositions and methods including B lymphocyte cell line expressing membrane immunoglobulin different from secreted immunoglobulin |
| 06/27/2013 | US20130164783 Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture |
| 06/27/2013 | US20130164782 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 06/27/2013 | US20130164294 Substance specific to human pd-1 |
| 06/27/2013 | CA2858963A1 Vaccines against hpv |
| 06/26/2013 | EP2606142A1 Method for inactivating proteases by ph change in a liquid obtained from a cell culture |
| 06/26/2013 | EP2605789A2 Modified relaxin polypeptides and their uses |
| 06/26/2013 | EP1392815B1 Enzymes having alpha amylase activity and methods of use thereof |
| 06/26/2013 | CN1942579B Site-specific incorporation of redox active amino acids into proteins |
| 06/26/2013 | CN103180447A Plant-based production of heterologous proteins |
| 06/26/2013 | CN103179982A Protein fusion constructs possessing thrombolytic and anticoagulant properties |
| 06/26/2013 | CN103179850A Recombinant production of steviol glycosides |
| 06/26/2013 | CN103173512A Process for extracting Penis et Testis Canis polypeptide through enzymatic method, and obtained Penis et Testis Canis polypeptide extract |
| 06/26/2013 | CN103173511A Method for industrially producing wheat glutamine peptide |
| 06/26/2013 | CN103173510A Preparation method of high-hydroxyproline-content deer collagen peptide |
| 06/26/2013 | CN103173509A Multi-nutrition active polypeptide with functions of slimming and body-building |
| 06/26/2013 | CN103173482A Wild type and mutant hFIX (human coagulation factor IX) Pichia pastoris expression vectors, and construction method and application thereof |
| 06/26/2013 | CN103173447A Novel beta-actin and rps21 promoters and uses thereof |
| 06/26/2013 | CN103173390A Chromobacterium violaceum strain and application thereof |
| 06/26/2013 | CN103172763A Coordinated process extraction method of biological active substances in crayfish by-products |
| 06/26/2013 | CN103172751A Fusion protein of PA4-Fc and coding gene and application thereof |
| 06/26/2013 | CN103172750A Immunosuppressive polypeptides and nucleic acids |
| 06/26/2013 | CN103172744A Monoclonal antibodies for specifically identifying B-Raf mutant proteins, preparation method and applications thereof |
| 06/26/2013 | CN103172743A Human Antibodies That Bind Cd22 And Uses Thereof |
| 06/26/2013 | CN103172742A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 06/26/2013 | CN103172739A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172738A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172737A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172735A Anti-system asc amino acid transporter 2 (asct2) antibody |
| 06/26/2013 | CN103172706A Preparation method of chick-pea oligopeptide with antioxidation function |
| 06/26/2013 | CN102021196B Method for producing recombinant human interleukin-21 by using Pichia pastoris |
| 06/26/2013 | CN101948898B Method for preparing nano oligopeptide collagen |
| 06/26/2013 | CN101889077B Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 06/25/2013 | US8470991 Immunocytokine sequences and uses thereof |
| 06/25/2013 | US8470977 Antibody against the CSF-1R |
| 06/25/2013 | US8470974 Method for highly sensitive detection of protein-protein interaction |
| 06/25/2013 | US8470973 Modular DNA-binding domains and methods of use |
| 06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
| 06/25/2013 | US8470581 Reduction of carbon dioxide emission during isoprene production by fermentation |
| 06/25/2013 | US8470577 Viral vectors and their use in therapeutic methods |
| 06/25/2013 | US8470576 Group of novel enantioselective microbial nitrile hydratases with broad substrate specificity |
| 06/25/2013 | US8470572 Ketoreductase polypeptides for the production of azetidinone |
| 06/25/2013 | US8470566 Microorganisms and methods for conversion of syngas and other carbon sources to useful products |
| 06/25/2013 | US8470561 GPCR comprising an IC2 insertion |
| 06/25/2013 | US8470560 CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines |
| 06/25/2013 | US8470558 Use of mammalian expression vector including T7 promoter and N-terminal HA tag for overexpression of human genes in E. coli |
| 06/25/2013 | US8470555 Protein substance having triple helix structure and manufacturing method therefor |
| 06/25/2013 | US8470554 Prokaryotic expression of soluble, active Dkk |
| 06/25/2013 | US8470552 Strategy to reduce lactic acid production and control PH in animal cell culture |
| 06/25/2013 | US8470545 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1) |
| 06/25/2013 | US8470544 Detection of dysplastic or neoplastic cells using anti-MCM3 antibodies |
| 06/25/2013 | US8470335 Recombinant SARS-CoV nsp12 and the use of thereof and the method for producing it |
| 06/25/2013 | US8470328 Purification method which prevents denaturation of an antibody |
| 06/25/2013 | US8470326 Monoclonal antibody therapy for pancreas cancer |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | CA2522894C Pharmaceutical composition comprising a bispecific antibody specific for epcam |